DLH Holdings Corp Suffers a 3.20% Decline in Stock Value by Mark Eisenberg 28.03.2024 DLH Holdings Corp (DLHC): Analyzing financial overview and stock performance in the healthcare and technology sectors amidst market volatility.
DLH Secures $23M NIDA Contract by Mark Eisenberg 13.02.2024 DLH Holdings secures $23 million contract with NIDA to provide IT services and an informatics system for drug abuse research. ...
Kintara’s REM-001: A Breakthrough in Breast Cancer Cure by Mark Eisenberg 12.02.2024 Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
Tonix Pharma’s Potential PTSD Cure: A Game-Changer? by Mark Eisenberg 12.02.2024 Tonix Pharmaceuticals receives FDA clearance for its OASIS trial, evaluating the efficacy of TNX-102 SL in treating acute stress reactions ...